Medtronic Acquires Scientia Vascular to Boost Neurovascular Portfolio

The deal enhances Medtronic's presence in the neurovascular market by integrating Scientia's guidewires and access tools.
March 13, 2026

Key Highlights

  • Medtronic's acquisition of Scientia Vascular is valued at $550 million, emphasizing its commitment to neurovascular innovation.
  • The integration aims to create a comprehensive platform for neurointerventional care, improving treatment options for stroke and cerebrovascular diseases.
  • This deal expands Medtronic's footprint in the growing neurovascular market and aligns with industry trends of consolidation and platform development.
ID 377817867 © Skypixel | Dreamstime.com
69b4202ce3b269c5062f4db3 Neurovascular Stent

Medtronic has agreed to acquire Scientia Vascular, a Utah-based developer of neurovascular access devices, in a transaction valued at $550 million. The deal is intended to strengthen Medtronic’s neurovascular portfolio, particularly technologies used to treat stroke and other cerebrovascular conditions.

Scientia Vascular develops guidewires and catheter-based access tools that enable clinicians to navigate the brain’s complex vascular pathways during minimally invasive procedures. Integrating these technologies with Medtronic’s existing therapeutic devices is expected to create a more comprehensive procedural platform for neurointerventional care.

The acquisition further expands Medtronic’s presence in the growing neurovascular market and reflects a broader trend of consolidation and platform development in stroke care technologies.

About the Author

Daniel Beaird
Email

Daniel Beaird

Editor-in-Chief

Daniel Beaird is Editor-in-Chief for Healthcare Purchasing News.

Sign up for our eNewsletters
Get the latest news and updates

Related

Logistics Giants Accelerate Push into Healthcare
2025 Supply Chain Department of the Year: Stanford Medicine